Medicaid clients and members rate Prime’s performance

We asked, and they told us how we’re doing. And it’s very good news.

September 24, 2019
The Medicaid team at Prime is committed to serving this important audience. We want to know how we’re doing. So, every year, we send clients and members a satisfaction survey. For two straight years, Medicaid clients scored Prime at 100 percent overall client satisfaction. Medicaid members have also returned very high satisfaction scores.

When our clients are satisfied, so are we

Our Medicaid clients specifically showed high satisfaction with Prime’s reporting, flexibility and our client engagement/account teams. Prime scored 100 percent in these areas:

  • Resolving problems in a timely manner
  • Member marketing communication and collateral (electronic and print)
  • Delivery of training or information on new products and services
  • Network pricing and strategy

Prime is pleased to report these high client satisfaction and high member satisfaction scores. Our most recent survey showed that 92 percent of our clients’ Medicaid members reported being “satisfied” or “very satisfied” with their prescription drug plan. For Prime, this is extremely good news, because we always put members first. It’s part of our purpose. It’s how we work with Blue Plans to make health care better.

Medicaid programming is an essential part of what a health plan offers its community. Diversity of a population’s needs, as well as regulatory oversight, demand a unique market-specific focus. Prime understands that this unique market requires a dedicated team. Prime’s Medicaid team really understands this market. We collaborate with our clients to find solutions that balance low cost and quality outcomes. This approach drives our success, providing value that benefits our clients and members.

Related news

Stories

May 15, 2024

Prime/MRx experts share clinical insights for migraine treatment

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

Stories

May 14, 2024

Prime/MRx real-world GLP-1 persistence and adherence data published in Journal of Managed Care & Specialty Pharmacy

Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended

Stories

May 14, 2024

Prime/MRx releases its first corporate social responsibility report

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey